Hejazi Seyed Hesam, Ahangari Ghasem, Pornour Majid, Deezagi Abdolkhaleagh, Aminzadeh Saeed, Ahmadkhaniha Hamid Reza, Akbari Mohamad Esmail
Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran E-mail :
Asian Pac J Cancer Prev. 2014;15(11):4455-8. doi: 10.7314/apjcp.2014.15.11.4455.
Breast cancer is a serious and potentially lethal multi-factor disease among 40-50 aged women in both developed and developing countries. Also, various studies have pointed to roles of neurotransmitters like serotonin in development of cancers, through action on various types of receptors. This study was conducted to evaluate serotonin receptor (5HT2AR and 5HT3AR) genes expression in peripheral blood mononuclear cells (PBMCs) of breast cancer patients in comparison with the healthy people and in the MCF7 cell line. Peripheral blood samples were obtained from 30 patients and 30 healthy individuals. Total RNA was extracted from PBMCs and MCF-7 cells. and 5HT2AR and 5HT3AR were detected by RT-PCR techniques. Finally, serotonin receptor gene expression variation in breast cancer patients and MCF-7 cells were determined by real time-PCR. This latter indicated significant promotion in expression of 5HT3AR and 5HT2AR in PBMCs in breast cancer patients but expression of 5HT2AR in the MCF-7 cell line was significantly decreased. In conclusion, after performing complimentary tests, determine of gene expression changes in serotonin receptors (5HT2AR and 5HT3AR) may be useful as a new approach in treatment of breast cancer based on use of antagonists.
在发达国家和发展中国家,乳腺癌是40至50岁女性中一种严重且可能致命的多因素疾病。此外,各种研究指出,血清素等神经递质通过作用于各种类型的受体,在癌症发展中发挥作用。本研究旨在评估乳腺癌患者外周血单个核细胞(PBMC)中血清素受体(5HT2AR和5HT3AR)基因的表达,并与健康人及MCF7细胞系进行比较。从30名患者和30名健康个体采集外周血样本。从PBMC和MCF - 7细胞中提取总RNA。通过RT - PCR技术检测5HT2AR和5HT3AR。最后,通过实时PCR测定乳腺癌患者和MCF - 7细胞中血清素受体基因的表达变化。后者表明乳腺癌患者PBMC中5HT3AR和5HT2AR的表达显著升高,但MCF - 7细胞系中5HT2AR的表达显著降低。总之,在进行补充试验后,确定血清素受体(5HT2AR和5HT3AR)的基因表达变化可能作为基于拮抗剂使用的乳腺癌治疗新方法有用。